News

Filter

Current filters:

Regulationzolpidem

US FDA lowers recommended dose for sleep drugs containing zolpidem

11-01-2013

The US Food and Drug Administration yesterday announced it is requiring the manufacturers of Ambien,…

AmbienAmbien CREdluarMedaNeurologicalNorth AmericaNovaDel PharmaPharmaceuticalRegulationSanofizolpidemZolpiMist

FDA approves Transcept Pharma’s Intermezzo mid-night insomnia treatment

24-11-2011

US drugmaker Transcept Pharmaceuticals (Nasdaq: TSPT) saw its shares jump 11% to $7.34 yesterday, after…

IntermezzoNeurologicalNorth AmericaPharmaceuticalPurdue PharmaRegulationTranscept Pharmazolpidem

Transcept Pharma expects further FDA delay for Intermezzo NDA

14-07-2011

Following a teleconference with the US Food and Drug Administration, neurosciences company Transcept…

IntermezzoNeurologicalNorth AmericaPharmaceuticalRegulationTranscept Pharmazolpidem

Back to top